DIPHENHYDRAMINE HYDROCHLORIDE 25MG- diphenhydramine hydrochloride 25mg tablet 
Strive Pharmaceuticals Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

RIGHT REMEDIES Allergy Relief 

Drug Facts

Active Ingredient (in each tablet)

Diphenhydramine HCl 25 mg

Purpose

Antihistamine

Uses

• temporarily relieves these symptoms due to hay fever or upper respiratory allergies:
      • runny nose             • sneezing
      • itchy, watery eyes  • itching of the nose and throat
• temporarily relieves these symptoms due to the common cold:
      • runny nose             • sneezing

Warnings

Do not use
• to make a child sleepy
• with other products containing diphenhydramine, even ones used on skin

Ask a doctor before use if you have
• a breathing problem such as emphysema or chronic bronchitis
• glaucoma
• trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

When using this product
• marked drowsiness may occur
• avoid alcoholic drinks
• alcohol, sedatives, and tranquilizers may increase drowsiness
• be careful when driving a motor vehicle or operating machinery
• excitability may occur, especially in children

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

Directions

• take every 4 to 6 hours, or as directed by doctor
• do not take more than 6 times in 24 hours

 adults & children 12 years of age and over take 1 to 2 tablets
 children 6 years of age to under 12 years of age take 1 tablet
 children under 6 years of age do not use

Other information

 each tablet contains: calcium 18.64 mg
• store at room temperature between 20 - 25°C (68-77°F).
• avoid excessive heat, cold and humidity.
• close cap tightly after use.

Inactive ingredients

croscarmellose sodium, dicalcium phosphate, D&C red #27 aluminum lake, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, silicon dioxide, talc, titanium dioxide

Questions or comments?

1-888-577-8033 Monday - Friday 8am - 4pm EST

RIGHT REMEDIES

Compare to the active ingredient of Benadryl® Allergy Ultratabs®*

Distributed by: Strive Pharmaceuticals Inc., East Brunswick, NJ 08816

Product of India

Packaged & Quality Assured in USA

REV.00-102022

READ AND KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

*This product is not manufactured or distributed by Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division., owner of the registered trademark Benadryl® Allergy Ultratabs®

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SEAL UNDER CAP IS BROKEN OR MISSING FROM BOTTLE

Packaging

AlergyRelief-148DrugFacts-148

DIPHENHYDRAMINE HYDROCHLORIDE 25MG 
diphenhydramine hydrochloride 25mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70692-148
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) DIPHENHYDRAMINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
TALC (UNII: 7SEV7J4R1U)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
Product Characteristics
ColorpinkScoreno score
ShapeCAPSULESize12mm
FlavorImprint Code DP
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70692-148-01100 in 1 PACKAGE; Type 0: Not a Combination Product12/28/2018
2NDC:70692-148-461 in 1 CARTON04/06/2023
272 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34112/20/2018
Labeler - Strive Pharmaceuticals Inc (080028013)

Revised: 4/2023
Document Id: 0b316623-6548-4d98-b42a-07103c3deb2b
Set id: b440eb2e-4de9-2b65-e053-2995a90abda8
Version: 4
Effective Time: 20230418
 
Strive Pharmaceuticals Inc